Repligen (RGEN) reported Q3 adjusted earnings Tuesday of $0.43 per diluted share, up from $0.23 a year earlier.

Analysts polled by Capital IQ expected $0.33.

Total revenue for the quarter ended Sept. 30 was $154.9 million, up from $141.2 million a year earlier.

Analysts surveyed by Capital IQ expected $153.3 million.

For 2024, the company said it now expects adjusted earnings of $1.50 to $1.58 per diluted share, compared with $1.42 to $1.49 previously. Analysts polled by Capital IQ expect $1.49.

Total reported revenue for the year is now expected to be in the range of $630 million to $639 million, narrowed from the previous outlook of $627 million to $642 million provided by the company in September. Analysts surveyed by Capital IQ expect $629.7 million.

Repligen's shares were up more than 7% in recent premarket activity.